Huntleigh Advisors, Inc.

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1367653 ST. LOUIS, MO

Position in ADPT

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

+$0 QoQ

Shares Held

23,293

+4.6% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Huntleigh Advisors, Inc. holds $7,935,528 across 5 Diagnostics & Research names. ADPT ranks #5 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTRA	Natera, Inc.	12,210	$3,314,404
2	DHR	Danaher Corp /De/	13,874	$2,642,719
3	VCYT	Veracyte, Inc.	25,918	$1,522,164
4	GH	Guardant Health, Inc.	3,041	$456,241
5	ADPT	Adaptive Biotechnologies Corp This page	23,293	$0

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	93,171	+4.6%	Shares	Sole	2026-08-04
2026-03-31	—	89,094	+2.8%	Shares	Sole	2026-04-21
2025-12-31	—	86,631	+5.6%	Shares	Sole	2026-01-29
2025-09-30	—	82,038	—	Shares	Sole	2025-10-30
No filing history on record for this holder in this stock.